Greenwich LifeSciences, Inc. (GLSI)
15.90
-0.05
(-0.31%)
USD |
NASDAQ |
Sep 08, 16:00
15.67
-0.23
(-1.45%)
Pre-Market: 20:00
Greenwich LifeSciences Total Assets (Quarterly) : 8.876M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.876M |
| March 31, 2026 | 10.51M |
| December 31, 2025 | 6.178M |
| September 30, 2025 | 3.807M |
| June 30, 2025 | 3.125M |
| March 31, 2025 | 2.751M |
| December 31, 2024 | 4.094M |
| September 30, 2024 | 5.825M |
| June 30, 2024 | 7.228M |
| March 31, 2024 | 5.510M |
| December 31, 2023 | 6.995M |
| September 30, 2023 | 9.150M |
| June 30, 2023 | 10.95M |
| March 31, 2023 | 11.92M |
| December 31, 2022 | 13.48M |
| September 30, 2022 | 15.65M |
| Date | Value |
|---|---|
| June 30, 2022 | 17.20M |
| March 31, 2022 | 19.75M |
| December 31, 2021 | 27.22M |
| September 30, 2021 | 28.92M |
| June 30, 2021 | 29.82M |
| March 31, 2021 | 30.42M |
| December 31, 2020 | 28.68M |
| September 30, 2020 | 6.274M |
| June 30, 2020 | 0.2807M |
| March 31, 2020 | 0.0258M |
| December 31, 2019 | 0.0267M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.1085M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.759M |
| Shareholders Equity (Quarterly) | 3.117M |
| Current Ratio | 1.541 |